Andrzej Rynkiewicz

Author PubWeight™ 68.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007 20.09
2 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007 9.43
3 Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med 2015 6.00
4 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007 4.59
5 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press 2007 1.76
6 C-344T polymorphism of the aldosterone synthase gene and blood pressure in the elderly: a population-based study. J Hypertens 2005 1.61
7 A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial. Eur Heart J 2012 1.45
8 Improvement of ultrasonic myocardial properties after aortic valve replacement for pure severe aortic stenosis: the predictive value of ultrasonic tissue characterization for left ventricle reverse remodeling. J Am Soc Echocardiogr 2010 1.41
9 Heart rate and double product in relation to insulin resistance in patients with hypertension and coronary artery disease. Kardiol Pol 2013 1.39
10 Association between the Pl(A) platelet glycoprotein GPIIIa polymorphism and extent of coronary artery disease. Int J Cardiol 2003 1.39
11 Clinical characteristics of patients undergoing surgical ventricular reconstruction by choice and by randomization. J Am Coll Cardiol 2010 1.20
12 Ventricular rupture in Takotsubo cardiomyopathy. Eur Heart J 2012 1.01
13 Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease. Am Heart J 2003 0.97
14 Effect of preload reduction by hemodialysis on myocardial ultrasonic characterization, left atrial volume, and Doppler tissue imaging in patients with end-stage renal disease. J Am Soc Echocardiogr 2006 0.93
15 [ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Rev Esp Cardiol 2007 0.90
16 Design and methodology of POWER, an open-label observation of the effect of primary care interventions on total cardiovascular risk in patients with hypertension. Fundam Clin Pharmacol 2011 0.90
17 Prognostic value of the six-minute walk test in heart failure patients undergoing cardiac surgery: a literature review. Rehabil Res Pract 2013 0.88
18 Management of left ventricular diastolic heart failure: is it only blood pressure control? Curr Opin Cardiol 2009 0.86
19 [Polish forum for prevention guidelines on cardiovascular risk assessment]. Kardiol Pol 2007 0.84
20 Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up. Eur Heart J 2010 0.82
21 [Review of epidemiologic studies in cardiology in Poland]. Kardiol Pol 2006 0.81
22 Aging in autonomic control by multifractal studies of cardiac interbeat intervals in the VLF band. Physiol Meas 2011 0.81
23 Exercise stress test and comparison of ST change with cardiac nucleotide catabolite production in patients with coronary artery disease. Cardiol J 2007 0.81
24 Effect of Antihypertensive Therapy on SCORE-Estimated Total Cardiovascular Risk: Results from an Open-Label, Multinational Investigation-The POWER Survey. Int J Hypertens 2013 0.79
25 [Practice guidelines 2007 for the treatment of arterial hypertension]. G Ital Cardiol (Rome) 2007 0.79
26 How to improve noninvasive coronary artery disease diagnostics in premenopausal women? The influence of menstrual cycle on ST depression, left ventricle contractility, and chest pain observed during exercise echocardiography in women with angina and normal coronary angiogram. Am Heart J 2008 0.78
27 Incidental diagnosis of unicuspid aortic valve in an asymptomatic adult. Kardiol Pol 2013 0.77
28 Angiotensin converting enzyme gene polymorphism is associated with severity of coronary artery disease in men with high total cholesterol levels. J Appl Genet 2012 0.77
29 Polish Forum for Prevention Guidelines on cardiovascular diseases prevention in children and adolescents. Kardiol Pol 2010 0.77
30 Recanalization of isolated chronic total occlusions in patients with stable angina. Int J Cardiol 2012 0.77
31 Autologous transplantation of bone marrow stem cells prepared by the point-of-care system in a patient with myocardial ischemia due to coronary artery chronic total occlusion. Int J Cardiol 2013 0.77
32 Left ventricular size, mass and function in relation to angiotensin-converting enzyme gene and angiotensin-II type 1 receptor gene polymorphisms in patients with coronary artery disease. Clin Chem Lab Med 2003 0.76
33 Noninvasive assessment of endothelial function and vascular parameters in patients with familial and nonfamilial hypercholesterolemia. Pol Arch Med Wewn 2014 0.76
34 Comparison of wavelet transform modulus maxima and multifractal detrended fluctuation analysis of heart rate in patients with systolic dysfunction of left ventricle. Ann Noninvasive Electrocardiol 2008 0.76
35 [A new version of cardiovascular risk assessment system and risk charts calibrated for Polish population]. Kardiol Pol 2015 0.76
36 Polish Forum for Prevention: a response to the European Society of Cardiology 'call for action' in Poland. Eur J Cardiovasc Prev Rehabil 2010 0.75
37 [Where are we in treatment of stable coronary disease--commentary on treatment RECENT]. Kardiol Pol 2009 0.75
38 Joint position statement of the Polish Cardiologic Society, the Polish Gynaecological Society and the Polish Menopause and Andropause Society on the effect of postmenopausal hormone replacement therapy on the cardiovascular system. Gynecol Endocrinol 2008 0.75
39 Polish Forum for Prevention of Cardiovascular Diseases Guidelines on prophylactic pharmacotherapy. Kardiol Pol 2011 0.75
40 Implantation of nitinol self-expanding carotid stent to release circumflex artery compression caused by mitral valve prosthesis. Eur Heart J 2011 0.75
41 Complexity of the heart rhythm after heart transplantation by entropy of transition network for RR-increments of RR time intervals between heartbeats. Conf Proc IEEE Eng Med Biol Soc 2013 0.75
42 Experimental hyperlipidaemia does not prevent preconditioning and it reduces ischemia-induced apoptosis. Int J Cardiol 2007 0.75
43 Polish Forum for Prevention Guidelines on the so-called new cardiovascular risk factors and markers, which have a potentially significant role in the strategy for the prevention of cardiovascular diseases. Kardiol Pol 2007 0.75
44 Major adverse cardiovascular events after drug-eluting stent implantation in patients with single chronic total occlusion: a single-center registry. J Invasive Cardiol 2013 0.75
45 Triple occurrence of Takotsubo cardiomyopathy. Kardiol Pol 2013 0.75
46 Assessment of Subclinical Atherosclerosis Using Computed Tomography Calcium Scores in Patients with Familial and Nonfamilial Hypercholesterolemia. J Atheroscler Thromb 2015 0.75
47 [Cardiologic health care in Poland--report from cardiology consultants in the year 2005]. Kardiol Pol 2005 0.75
48 [Severe hypercholesterolaemia - when to use the proprotein convertase subtilisin-kexin type 9 protease inhibitors (PCSK9 inhibitors)? Polish Society of Cardiology experts' group statement]. Kardiol Pol 2016 0.75
49 [Transcatheter aortic valve implantation for degeneration of biological aortic prosthesis]. Kardiol Pol 2012 0.75
50 The successful treatment of cardiogenic shock with primary percutaneous coronary intervention (T-stenting) of total occluded unprotected left main performed during cardiopulmonary resuscitation. Kardiol Pol 2015 0.75
51 The Polish MacNew heart disease heath-related quality of life questionnaire: A validation study. Cardiol J 2015 0.75
52 Cerivastatin and hypercholesterolemia reduce apoptosis of cardiomyocytes in guinea pig papillary muscle subjected to hypoxia/reoxygenation. Pharmacol Rep 2006 0.75
53 Basic laboratory parameters as predictors of in-hospital death in patients with acute decompensated heart failure - data from a large single-centre cohort. Kardiol Pol 2016 0.75
54 [Ventricular septal rupture complicating surgically treated left ventricular free wall rupture in a patient with acute myocardial infarction. A case report]. Kardiol Pol 2006 0.75
55 [Giant cell arteritis involving the aorta and pulmonary trunk]. Kardiol Pol 2013 0.75
56 Program running versus problem solving: two patterns of cardiac response. Int J Psychophysiol 2012 0.75
57 Effectiveness of hypertension treatment assessed by blood pressure level achieved in primary care setting in Poland. Blood Press 2003 0.75
58 [Magnetic resonance imaging in a patient with an implantable cardioverter-defibrillator]. Kardiol Pol 2013 0.75
59 Sympathetic neural responses to coronary occlusion during balloon angioplasty. J Hypertens 2007 0.75
60 Contemporary trans-catheter treatment of severe aortic stenosis. Kardiol Pol 2011 0.75
61 An interventional percutaneous approach of posttraumatic left coronary artery fistula repair. J Invasive Cardiol 2012 0.75
62 Takotsubo cardiomyopathy related to compound electrolyte aberration and anemia in Crohn's disease. Int J Cardiol 2011 0.75
63 ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design. Vnitr Lek 2017 0.75
64 Morning and afternoon serum cortisol level in patients with post-myocardial infarction depression. Cardiol J 2017 0.75
65 [Opinion of the Polish Cardiological Society and Polish National Cardiological Authority about cardiology medical specialty, presented at meeting at National Health Department, 25th of February, 2009, in presence of Health Minister Ewa Kopacz]. Kardiol Pol 2009 0.75
66 Polish Forum for Prevention Guidelines for screening procedures for cardiovascular diseases. Kardiol Pol 2011 0.75
67 ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic Epidemiology. Vnitr Lek 2017 0.75
68 Early-generation versus new-generation drug-eluting stents in isolated chronic total occlusion: on the road to extinction? J Invasive Cardiol 2014 0.75
69 [Joint position statement of Polish Gynecologic Society, Polish Cardiological Society, and Polish Menopause and Andropause Society on the effect of hormone replacement therapy on cardiovascular system]. Kardiol Pol 2009 0.75
70 RUN/EDIT information processing mode and phasic cardiac acceleration. Psychophysiology 2008 0.75
71 [Catastrophic antiphospholipid syndrome complicated by cardiogenic shock - a case report]. Kardiol Pol 2009 0.75
72 Acute coronary artery thrombosis during the postpartum period complicated by cardiogenic shock and AH1N1 infection. Kardiol Pol 2012 0.75
73 [Management in familial hypercholesterolaemia in children and adolescents. Position of the Lipid Expert Forum]. Kardiol Pol 2013 0.75
74 [Periodontal and dental state of patients with coronary heart disease]. Przegl Lek 2004 0.75
75 Mental task demands and cardiovascular response patterns. Biol Psychol 2010 0.75
76 [Availability of coronarography based on the examinations performed in the Haemodynamic Laboratory of the Medical University of Gdansk]. Wiad Lek 2002 0.75
77 Polish forum for prevention guidelines on metabolic syndrome. Kardiol Pol 2010 0.75
78 Successful recanalisation of isolated chronic total occlusions improves outcomes in long-term observation: a case-control study. Kardiol Pol 2013 0.75
79 The disk of bileaflet mechanical mitral valve prosthesis jammed by ruptured papillary muscle. J Thorac Cardiovasc Surg 2006 0.75
80 [Optimum heart rate - the current goal of cardiovascular therapy. Position statement of the Polish Cardiac Society Working Group on Cardiovascular Drug Therapy]. Kardiol Pol 2012 0.75
81 Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum. Pol Arch Med Wewn 2013 0.75